Niranjan Sardesai Net Worth & Insider Trades
Niranjan Sardesai - Chief Operating Officer, Inovio Pharmaceuticals, Inc
What is Niranjan Sardesai's Net Worth?
The current estimated net worth of Inovio Pharmaceuticals, Inc's Chief Operating Officer, Niranjan Sardesai, is estimated to be about $341.81K . Niranjan Sardesai owns about 48,434 units of Inovio Pharmaceuticals, Inc common stock. In the last 9 years at Inovio Pharmaceuticals, Inc, Niranjan Sardesai has sold an estimated value of $379.75K worth.
What is Niranjan Sardesai's Past Insider Trading?
Niranjan Sardesai's largest purchase order was 33,116 units , worth over $202.67K on August 30, 2016. Niranjan Sardesai's largest sale order was 21,800 units , worth over $202.73K on August 30, 2016. In total, Niranjan Sardesai has made about 19 transactions over 9 years of their time at Inovio Pharmaceuticals, Inc. Niranjan Sardesai usually trades in March, with the busiest year in 2016, 2012, 2017 and 2014.
Niranjan Sardesai
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Niranjan Sardesai's' Mailing Address?
- Mailing address is Vgx Pharmaceuticals, Inc. 450 Sentry Parkway Blue Bell PA 19422 PA
Inovio Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| J. Joseph Kim, Ph.D. | 2020 | $694,645 | $3,499,999 | - | $500,032 | $13,000 | $4,707,676 |
| J. Joseph Kim, Ph.D. | 2019 | $837,735 | $638,274 | $642,803 | $457,222 | $12,500 | $2,588,534 |
| J. Joseph Kim, Ph.D. | 2018 | $726,798 | $1,545,687 | $391,922 | $407,386 | $9,250 | $3,081,043 |
| Peter D. Kies | 2020 | $445,639 | $1,499,996 | - | $198,260 | $10,010 | $2,153,905 |
| Peter D. Kies | 2019 | $523,285 | $215,096 | $216,712 | $177,833 | $10,010 | $1,142,936 |
| Peter D. Kies | 2018 | $449,886 | $354,783 | $358,612 | $158,321 | $10,010 | $1,331,612 |
| Laurent M. Humeau, Ph.D. | 2020 | $430,769 | $1,499,996 | - | $193,600 | $13,000 | $2,137,365 |
| Laurent M. Humeau, Ph.D. | 2019 | $393,903 | $199,398 | $200,970 | $165,760 | $12,500 | $972,531 |
| Jacqueline E. Shea, Ph.D. | 2020 | $430,769 | $1,499,996 | - | $193,600 | $12,946 | $2,137,311 |
| Jacqueline E. Shea, Ph.D. | 2019 | $335,000 | $181,000 | $465,120 | $165,760 | $10,154 | $1,157,034 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1055726/000105572621000033/ino-2021xproxy.htm
What are Inovio Pharmaceuticals, Inc's Past Insider Trades?
Inovio Pharmaceuticals, Inc's most recent insider trade came on June 5, 2023 by Lota Zoth who sold 5,700 units worth $3.19K . In the last 17 years, insiders at Inovio Pharmaceuticals, Inc have sold an estimated value of $38.73M and bought an estimated value of $11.69M worth of shares. Insider trading is most common in May, with the busiest year in 2021 and 2011. The most active traders at the company are Jong Joseph Kim, Chief Executive Officer, Peter Kies, CFO, and David Greenhouse Austin Marxe .
INOVIO PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||